ScoreWhy is Valerio Therapeutics SA ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-12.99%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-12.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.12
Tax Ratio
10.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-7.42
EV to EBIT
-10.35
EV to EBITDA
-13.50
EV to Capital Employed
12.54
EV to Sales
45.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-121.20%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
ROCE(HY)
Highest at 0%
DEBT-EQUITY RATIO
(HY)
Lowest at -174.75 %
OPERATING PROFIT(Q)
Highest at EUR -1.89 MM
PRE-TAX PROFIT(Q)
Highest at EUR -0.67 MM
NET PROFIT(Q)
Highest at EUR -0.21 MM
EPS(Q)
Highest at EUR -0
-8What is not working for the Company
INTEREST(HY)
At EUR 0.3 MM has Grown at 398.33%
OPERATING CASH FLOW(Y)
Lowest at EUR -25.54 MM
RAW MATERIAL COST(Y)
Grown by 148,254% (YoY
Here's what is working for Valerio Therapeutics SA
Operating Profit
Highest at EUR -1.89 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (EUR MM)
Pre-Tax Profit
Highest at EUR -0.67 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Pre-Tax Profit
At EUR -0.67 MM has Grown at 94.25%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (EUR MM)
Net Profit
Highest at EUR -0.21 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (EUR MM)
Net Profit
At EUR -0.21 MM has Grown at 98.1%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (EUR MM)
EPS
Highest at EUR -0
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (EUR)
Debt-Equity Ratio
Lowest at -174.75 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Valerio Therapeutics SA
Interest
At EUR 0.3 MM has Grown at 398.33%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (EUR MM)
Operating Cash Flow
Lowest at EUR -25.54 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (EUR MM)
Raw Material Cost
Grown by 148,254% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
